| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 08/16/2001 | WO2000069473A3 Macromolecular carrier for drug and diagnostic agent delivery |
| 08/16/2001 | US20010014461 For diagnosis, drug discovery; both parallel and muliplex analyte processing capabilities; retentate chromatography is a combinatorial method to provide high information resolution of analytes in complex mixtures |
| 08/16/2001 | US20010014325 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 08/16/2001 | EP1123401A1 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP) |
| 08/16/2001 | EP1123117A2 Hyperpolarized noble gas extraction methods, masking methods, and associated transport containers |
| 08/16/2001 | EP1123116A2 Contrast agents with variable oxidation states |
| 08/16/2001 | CA2400699A1 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 08/16/2001 | CA2400092A1 Diagnostic and therapeutic compositions and methods for affecting tumor growth using oxygen mimetic agents |
| 08/16/2001 | CA2399067A1 Method for diagnosing efficacy of xenotypic antibody therapy |
| 08/15/2001 | CN1069633C Iodinated X-ray contrast media |
| 08/14/2001 | US6274729 Prevent tissue damage |
| 08/14/2001 | US6274713 Suited to enhance images of selected mammalian organs, tissues, cells, and the like, in vivo, using magnetic resonance imaging, x-ray, gamma scintigraphy, and ct scanning |
| 08/14/2001 | US6274347 Contacting antibody producing cells with fusion protein of extracellular portion of human leukocyte adhesion molecule-1 and constant region of human immunoglobulin g1, then isolating antibodies |
| 08/14/2001 | US6274121 Superparamagnetic particles, process for their manufacture and use |
| 08/14/2001 | US6274120 Dry microparticles for use as a contrast agent |
| 08/14/2001 | US6274118 Localization and therapy of non-prostatic endocrine cancer with agents directed against prostate specific antigen |
| 08/14/2001 | CA1341285C Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines |
| 08/09/2001 | WO2001056612A2 Animal model for testing of immunotherapies |
| 08/09/2001 | WO2001056582A1 Tracking gene expression and metabolic processes in subjects |
| 08/09/2001 | WO2000078361A3 Methods of imaging and targeting tumor vasculature |
| 08/09/2001 | WO2000062813A3 Cationic peg-lipids and methods of use |
| 08/09/2001 | US20010012636 Chewing gum with pH indicator |
| 08/09/2001 | US20010012522 Multilayer; shell, core |
| 08/09/2001 | US20010012507 Phospholipid stabilized microbubbles |
| 08/08/2001 | EP1122318A2 Diagnostic method for the detection of polymorphisms related to the human urokinase plasminogen activator receptor |
| 08/08/2001 | EP1121456A1 In vitro and in vivo models for screening compounds to prevent glucocorticoid-induced bone destruction |
| 08/08/2001 | EP1121158A2 Method for viewing tumor tissue located within a body cavity |
| 08/08/2001 | CN1307488A Methods for detecting lesions in dense tissue using LHRH antagonists |
| 08/08/2001 | CN1306863A Sulfoamino radical containing paramagnetic metal compound as magnetic resonance imaging contrast agent |
| 08/07/2001 | US6270749 Use of Texaphyrin in ocular diagnosis and therapy |
| 08/07/2001 | US6270748 Contrast enhancing agent having a polymeric core and polymeric shell |
| 08/07/2001 | US6269818 Photoactivation of endogenous porphyrins for treatment of psoriasis |
| 08/07/2001 | US6269648 Hyperpolarized gas containers, solenoids, transport and storage devices and associated transport and storage methods |
| 08/02/2001 | WO2001055656A2 Hyperpolarization of a gas |
| 08/02/2001 | WO2001054771A2 Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor |
| 08/02/2001 | WO2001054696A1 In vivo stain compounds and methods of use to identify dysplastic tissue |
| 08/02/2001 | WO2001054680A2 Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor |
| 08/02/2001 | WO2001054672A2 Closure of bacterial ghosts |
| 08/02/2001 | WO2000071169A3 Magnetic resonance tracking of magnetically labeled cells |
| 08/02/2001 | US20010011076 Administering protein kinase c inhibitor and antitumor agent |
| 08/02/2001 | US20010010811 Contrast agents |
| 08/02/2001 | DE10003241A1 Verschließen von Bakterienghosts Closing bacterial ghosts |
| 08/02/2001 | CA2423122A1 Closure of bacterial ghosts |
| 08/02/2001 | CA2366759A1 In vivo stain compounds and methods of use to identify dysplastic tissue |
| 08/01/2001 | EP1119614A2 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof |
| 08/01/2001 | EP1119371A1 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY |
| 08/01/2001 | EP1119315A2 Delivery of phosphoinositide polyphosphates into cells |
| 08/01/2001 | EP1119251A1 Methods of screening for apoptosis-controlling agents for bone anabolic therapies and uses thereof |
| 08/01/2001 | EP0698119B1 Rapid diagnostic procedure for ivermectin resistance |
| 08/01/2001 | EP0631503B1 Use of vasoactive intestinal peptide (vip) to induce temporary paralysis of the gastrointestinal tract |
| 08/01/2001 | EP0569583B1 Controlled use of polyether-substituted tumor agents in diagnosis and therapy |
| 08/01/2001 | CN1306442A Improement in or relating to contrast agents |
| 08/01/2001 | CN1306441A Pare-hydrogen labelled agents and their use in magnetic resonance imaging |
| 07/31/2001 | US6267116 Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug |
| 07/31/2001 | CA2237263C Radionuclide labeling of vitamin b12 and coenzymes thereof |
| 07/31/2001 | CA2055612C Oligonucleotidic sequences for the amplification of hiv-2 and siv-type retrovirus genome, and their applications for the in vitro diagnosis of infections due to these virus |
| 07/26/2001 | WO2001053355A1 An in vivo screen using chemical inducers of dimerization |
| 07/26/2001 | WO2001053324A2 Novel haptotactic peptides |
| 07/26/2001 | WO2001053292A1 Dendrimer precursor dyes for imaging |
| 07/26/2001 | WO2001052906A2 Magnetic resonance imaging using contrast agents prodrugs bioactivated by enzymatic cleavage |
| 07/26/2001 | WO2001052899A1 Chelating agents and method for their use as tandem metal chelators and hydrophilic spacers for medical diagnosis and therapy |
| 07/26/2001 | WO2001052898A1 Methods for incorporating metal chelators at carboxyl-terminal site of peptides |
| 07/26/2001 | WO2001052893A1 Composition consisting of an active ingredient and a therapeutically active delivery system, especially in the treatment of angiogenesis |
| 07/26/2001 | WO2001052835A2 Free radical scavengers for the treatment of premature birth |
| 07/26/2001 | WO2001052746A1 Versatile hydrophilic dyes |
| 07/26/2001 | WO2001052745A1 Novel dyes |
| 07/26/2001 | WO2001052744A1 Hydrophilic cyanine dyes |
| 07/26/2001 | WO2001052743A1 Tunable indocyanine dyes for biomedical applications |
| 07/26/2001 | WO2001052741A1 Luminescent in vivo glucose measurement |
| 07/26/2001 | WO2000059547A3 Method of detecting endometriosis |
| 07/26/2001 | US20010009658 Methods for dissolving hyperpolarized 129 Xe gas using microbubbles |
| 07/26/2001 | US20010009656 For treating solid mass tumors via catheter delivery, comprising a biocompatible polymer, a biocompatible solvent and a water insoluble radioisotope of given radioactive content |
| 07/26/2001 | CA2398086A1 Composition consisting of an active ingredient and a therapeutically active delivery system, especially in the treatment of angiogenesis |
| 07/26/2001 | CA2398010A1 An in vivo screen using chemical inducers of dimerization |
| 07/26/2001 | CA2397833A1 Novel haptotactic peptides |
| 07/25/2001 | EP1118337A2 Echogenic coating |
| 07/25/2001 | EP1117833A1 A novel method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers |
| 07/25/2001 | EP1117439A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 07/25/2001 | EP0597865B1 Heavy metal clusters for use as imaging agents |
| 07/25/2001 | CN1304729A Method for infecting mouse with pylorospirobacillus |
| 07/24/2001 | US6265610 Contrast media for angiography |
| 07/24/2001 | US6264959 Ultrasonic contrast agents, process for their preparation and their use as a diagnostic and therapeutic agent |
| 07/24/2001 | US6264922 Liquid drops containing mixture of liquid, crystal therapeutic agent and surfactant |
| 07/24/2001 | US6264920 Tunable indocyanine dyes for biomedical applications |
| 07/24/2001 | US6264919 Restoring fluorescence; adding biocompatible solvent |
| 07/24/2001 | US6264918 Hollow microcapsules for methods of ultrasound imaging |
| 07/24/2001 | US6264917 Targeted ultrasound contrast agents |
| 07/24/2001 | US6264916 N,N-dimethyldiatrizoic acid and its conjugates as hepatobiliary agents for x-ray CT imaging |
| 07/24/2001 | US6264914 Contrast agents |
| 07/24/2001 | CA2065299C Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| 07/19/2001 | WO2001051095A2 Paramagnetic dota derivatives, pharmaceutical agents containing the same, methods for the production thereof and their use for the mr imaging of necrosis and infarction |
| 07/19/2001 | WO2001051094A1 Diagnostic method using a deuterated agent for imaging specific tissue |
| 07/19/2001 | WO2001050846A1 Intra-vascular administration of particles to induce pulmonary hypertension, pulmonary hypertension syndrome, and ascites in animals |
| 07/19/2001 | US20010008626 Ultrasound contrast agents and methods of making and using them |
| 07/19/2001 | DE19948650A1 Contrast agent formulations containing perfluoroalkylated dye and other perfluoroalkylated compound, having high organ specificity, especially for lymph nodes, useful e.g. in fluorescence or near infrared diagnosis |
| 07/19/2001 | DE10000675A1 Valve or compressor including sealing rings, for use under high vacuum conditions, especially in efficient production of nuclear spin polarized helium-3 gas for use in magnetic resonance tomography |
| 07/18/2001 | EP1116690A2 Production of nuclear spin polarized Helium-3 gas |
| 07/18/2001 | EP1115866A1 Cystine knot growth factor mutants |
| 07/18/2001 | EP1115426A1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer |
| 07/18/2001 | EP1115407A1 Composition, method and apparatus for inducing controlled cognitive disorder |